Forum Pharmaceuticals, Inc.
9Patents
9Active
9Granted
43Portfolio score
Filing activity: Dec 20, 2012 → Jan 20, 2016
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9108961B2 | Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride | Chemistry; Metallurgy | 3 | Active |
| US8815933B2 | Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof | Human Necessities | 2 | Active |
| US8946222B2 | Phenoxymethyl heterocyclic compounds | Chemistry; Metallurgy | 1 | Active |
| US9265767B2 | 1,2-disubstituted heterocyclic compounds | Chemistry; Metallurgy | 1 | Active |
| US9550767B2 | Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate | Chemistry; Metallurgy | 0 | Active |
| US9273044B2 | Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate | Chemistry; Metallurgy | 0 | Active |
| US9585877B2 | Methods of maintaining, treating or improving cognitive function | Human Necessities | 0 | Active |
| US8933074B2 | 1,2-disubstituted heterocyclic compounds | Chemistry; Metallurgy | 0 | Active |
| US9193749B2 | Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.